Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Furosemide in Premature Infants at Risk of BPD
NCT02527798Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Nov 2015
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in bronchopulmonary dysplasia (BPD), sponsored by University of North Carolina at Chapel Hill. Started Nov 2015; status: completed.
02
Drugs
furosemide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT02527798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527798.